These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1604677)

  • 1. Short-term treatment by implantable pump does not impair lipoprotein pattern in IDDM patients.
    Hanaire-Broutin H; Lorenzini F; Lacombe S; Lafon F; Solera ML; Tauber JP
    Transplant Proc; 1992 Jun; 24(3):947. PubMed ID: 1604677
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term treatment of type I diabetes in 28 patients using two different implantable programmable pumps.
    Jeandidier N; Pinget M; Keipes M; Louy S; Charton MN; Marescaux J; Reville P
    Transplant Proc; 1992 Jun; 24(3):940-1. PubMed ID: 1604674
    [No Abstract]   [Full Text] [Related]  

  • 3. Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type I diabetic patients.
    Guerci B; Igau B; Ziegler O; Crea T; Fruchart JC; Drouin P; Fievet C
    Metabolism; 1996 Apr; 45(4):430-4. PubMed ID: 8609827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
    Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
    Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipoproteins and apolipoproteins in insulin-dependent and young non-insulin-dependent Arab women.
    al-Muhtaseb N; al-Yuosuf AR; Bajaj JS
    Acta Diabetol Lat; 1991; 28(1):61-9. PubMed ID: 1862693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal insulin delivery decreases the levels of chylomicron remnants in patients with IDDM.
    Georgopoulos A; Saudek CD
    Diabetes Care; 1994 Nov; 17(11):1295-9. PubMed ID: 7821170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 8. Is Pump Therapy for All with Type 1 Diabetes?
    Wilson DM
    Diabetes Technol Ther; 2016 May; 18(5):280-1. PubMed ID: 27159783
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormonal contraception in women with IDDM. Influence on glycometabolic control and lipoprotein metabolism.
    Petersen KR; Skouby SO; Vedel P; Haaber AB
    Diabetes Care; 1995 Jun; 18(6):800-6. PubMed ID: 7555506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid and lipoprotein levels in young IDDM patients.
    Schober E
    Diabetes Care; 1993 Apr; 16(4):664-5. PubMed ID: 8462404
    [No Abstract]   [Full Text] [Related]  

  • 11. Normalization of composition of triglyceride-rich lipoprotein subfractions in diabetic subjects during insulin infusion with programmable implantable medication system.
    Georgopoulos A; Saudek CD
    Diabetes Care; 1992 Jan; 15(1):19-26. PubMed ID: 1737538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control.
    Gonen B; White N; Schonfeld G; Skor D; Miller P; Santiago J
    Metabolism; 1985 Jul; 34(7):675-9. PubMed ID: 3874341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein compositional abnormalities in type 1 (insulin-dependent) diabetic patients.
    Manzato E; Zambon A; Zambon S; Nosadini R; Doria A; Marin R; Crepaldi G
    Acta Diabetol; 1993; 30(1):11-6. PubMed ID: 8329725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure to achieve tight control of plasma cholesterol and apolipoprotein B with intraperitoneal insulin infusion in type 1 diabetes.
    Monnier LH; Pares Herbute N; Guastamacchia E; Colette C; Selam JL; Crastes de Paulet P; Beraud JJ; Mirouze J
    Diabetes Res Clin Pract; 1989 Jan; 6(1):69-73. PubMed ID: 2702919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin pump treatment in children and adolescents with type 1 diabetes].
    Bittner C; von Schütz W; Danne T
    MMW Fortschr Med; 2004 May; 146(20):35-7. PubMed ID: 15344731
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diabetes and the insulin pump: functional results after 5 consecutive years of permanent use].
    Mirouze J; Rouault R; Misse P; Millet P; Bordat B; Selam JL; Boudet C
    Bull Soc Ophtalmol Fr; 1989 Mar; 89(3):437-40. PubMed ID: 2598391
    [No Abstract]   [Full Text] [Related]  

  • 17. Intensive management of type 1 diabetes in young children.
    Kaufman FR
    Lancet; 2005 Feb 26-Mar 4; 365(9461):737-8. PubMed ID: 15733703
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of apolipoprotein AIV and lipoproteins to glycaemic control in young people with insulin-dependent diabetes mellitus.
    Attia N; Touzani A; Lahrichi M; Balafrej A; Kabbaj O; Girard-Globa A
    Diabet Med; 1997 Mar; 14(3):242-7. PubMed ID: 9088774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapy of IDDM with an implantable insulin pump. The Implantable Insulin Pump Trial Study Group.
    Dunn FL; Nathan DM; Scavini M; Selam JL; Wingrove TG
    Diabetes Care; 1997 Jan; 20(1):59-63. PubMed ID: 9028695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable programmable insulin pumps for the treatment of diabetes.
    Waxman K; Turner D; Nguyen ST; Selam JL; Charles MA
    Arch Surg; 1992 Sep; 127(9):1032-6; discussion 1036-7. PubMed ID: 1387526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.